Format
Sort by
Items per page

Send to

Choose Destination

Best matches for atherosclerosis Chlamydia trachomatis:

Search results

Items: 1 to 20 of 55

1.

Lycopene Inhibits Propagation of Chlamydia Infection.

Zigangirova NA, Morgunova EY, Fedina ED, Shevyagina NV, Borovaya TG, Zhukhovitsky VG, Kyle NH, Petyaev IM.

Scientifica (Cairo). 2017;2017:1478625. doi: 10.1155/2017/1478625. Epub 2017 Aug 29.

2.

In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil.

Freitas LS, Almeida NCC, Freitas Queiroz MA, Zaninotto MM, Fuzii HT, Ribeiro-Silva A, Vallinoto AC, Ishak MO, Quaresma JA, Ishak R.

Infect Drug Resist. 2017 Apr 10;10:109-114. doi: 10.2147/IDR.S123801. eCollection 2017.

3.

Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.

Marangoni A, Fiorino E, Gilardi F, Aldini R, Scotti E, Nardini P, Foschi C, Donati M, Montagnani M, Cevenini M, Franco P, Roda A, Crestani M, Cevenini R.

Atherosclerosis. 2015 Aug;241(2):471-9. doi: 10.1016/j.atherosclerosis.2015.05.023. Epub 2015 Jun 3.

PMID:
26086356
4.

Preparation and evaluation of monoclonal antibodies against chlamydial protease-like activity factor to detect Chlamydia pneumoniae antigen in early pediatric pneumonia.

Zheng J, Ding T, Chen Z, Fang H, Li H, Lu H, Wu Y.

Eur J Clin Microbiol Infect Dis. 2015 Jul;34(7):1319-26. doi: 10.1007/s10096-015-2343-8. Epub 2015 Mar 12.

PMID:
25761740
5.

[Chlamydial infection of the central nervous system. Laboratory diagnosis and clinic and morphological features].

Vaĭnshenker IuI, Nuralova IV, Onishenko LS.

Arkh Patol. 2014 Jan-Feb;76(1):57-62. Review. Russian.

PMID:
24745195
6.

Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells.

Campbell LA, Puolakkainen M, Lee A, Rosenfeld ME, Garrigues HJ, Kuo CC.

Microbes Infect. 2012 Jan;14(1):43-9. doi: 10.1016/j.micinf.2011.08.003. Epub 2011 Aug 30.

7.

Monoclonal antibodies against lipopolysaccharide of Chlamydia trachomatis with cross reactivity to human ApoB.

Petyaev IM, Zigangirova NA, Tsibezov VV, Ross A, Bashmakov YK.

Hybridoma (Larchmt). 2011 Apr;30(2):131-6. doi: 10.1089/hyb.2010.0107.

PMID:
21529285
8.

Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract.

Linhares IM, Witkin SS.

Cell Stress Chaperones. 2010 Sep;15(5):467-73. doi: 10.1007/s12192-010-0171-4. Epub 2010 Feb 25. Review.

9.

Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin.

Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJ.

PLoS Pathog. 2009 Aug;5(8):e1000552. doi: 10.1371/journal.ppat.1000552. Epub 2009 Aug 28. Review.

10.

Sonodynamic therapy.

Tachibana K, Feril LB Jr, Ikeda-Dantsuji Y.

Ultrasonics. 2008 Aug;48(4):253-9. doi: 10.1016/j.ultras.2008.02.003. Epub 2008 Mar 7.

PMID:
18433819
11.

[Underestimated problem of Chlamydia infections].

Woźniakowska-Gesicka T, Wiśniewska-Ligier M, Kiciński P, Gesicki T.

Przegl Epidemiol. 2008;62 Suppl 1:133-41. Review. Polish.

PMID:
22320048
12.

Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells.

Gérard HC, Fomicheva E, Whittum-Hudson JA, Hudson AP.

Microb Pathog. 2008 Apr;44(4):279-85. Epub 2007 Oct 18.

PMID:
17997273
13.

Development potential of rifalazil and other benzoxazinorifamycins.

Rothstein DM, Shalish C, Murphy CK, Sternlicht A, Campbell LA.

Expert Opin Investig Drugs. 2006 Jun;15(6):603-23. Review.

PMID:
16732714
14.

Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients.

Maggi P, Monno R, Chirianni A, Gargiulo M, Carito V, Fumarola L, Perilli F, Lillo A, Bellacosa C, Panebianco A, Epifani G, Regina G.

In Vivo. 2006 May-Jun;20(3):409-13.

15.

EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.

Schmidt R, Redecke V, Breitfeld Y, Wantia N, Miethke T, Massberg S, Fischel S, Neumann FJ, Schömig A, May AE.

Thromb Haemost. 2006 Jan;95(1):151-8.

PMID:
16543974
16.

The many faces of chlamydiae.

Ngeow Y.

Malays J Pathol. 2000 Dec;22(2):55-64. Review.

PMID:
16329536
17.

Chlamydia and antigenic mimicry.

Bachmaier K, Penninger JM.

Curr Top Microbiol Immunol. 2005;296:153-63. Review.

PMID:
16323424
18.

[Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae].

Zele-Starcević L, Plecko V, Budimir A, Kalenić S.

Acta Med Croatica. 2004;58(4):329-33. Review. Croatian.

PMID:
15700690
19.

Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells.

Krüll M, Kramp J, Petrov T, Klucken AC, Hocke AC, Walter C, Schmeck B, Seybold J, Maass M, Ludwig S, Kuipers JG, Suttorp N, Hippenstiel S.

Infect Immun. 2004 Nov;72(11):6615-21.

20.

Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathway.

Al-Younes HM, Brinkmann V, Meyer TF.

Infect Immun. 2004 Aug;72(8):4751-62.

Supplemental Content

Loading ...
Support Center